Literature DB >> 32527865

Off-label use of tofacitinib: a potential treatment option for SAPHO syndrome.

Wenhui Xie1, Hong Huang1, Zhuoli Zhang2.   

Abstract

Entities:  

Keywords:  antirheumatic agents; outcome assessment, health care; synovitis

Mesh：

Substances：

Year:  2020        PMID： 32527865     DOI： 10.1136/annrheumdis-2020-217854

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   27.973


× No keyword cloud information.
  2 in total

1.  SAPHO Syndrome Complicated by Ankylosing Spondylitis Successfully Treated With Tofacitinib: A Case Report.

Authors:  Fangfang Yuan; Jing Luo; Qiong Yang
Journal:  Front Immunol       Date:  2022-05-25       Impact factor: 8.786

Review 2.  New insights on multigenic autoinflammatory diseases.

Authors:  Petros Efthimiou; Olga Petryna; Priscila Nakasato; Apostolos Kontzias
Journal:  Ther Adv Musculoskelet Dis       Date:  2022-09-03       Impact factor: 3.625
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.